Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PCRX · against 557 other Healthcare companies listed in US-listed
Ranked #207 of 558 · scores higher than 63% of peers
Bars: peers in each 10-point band of the profitability score33 peers with a profitability score of 40–49, including PCRX · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | PCRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | 1.9% | -7.0% | 59% | 33% | |
| Operating marginHigher is better · 479 reported | 2.7% | -2.4% | 58% | 33% | |
| Return on assetsHigher is better · 582 reported | 1.2% | -7.8% | 64% | 33% | |
| Return on equityHigher is better · 531 reported | 2.0% | -19.7% | 66% | Context only | |
| Gross marginHigher is better · 601 reported | 79.2% | 43.9% | 84% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 202 | 1.3B USD | 44 | 58 | |
| 206 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 45.2B USD |
| 43 |
| 46 |
| 207 | 3.1B USD | 42 | 53 |
| 207 | 1.1B USD | 42 | 43 |
| 207 | 1.5B USD | 42 | 59 |
| 210 | 1.2B USD | 41 | 42 |
| 210 | 17M USD | 41 | 16 |
| 210 | 10.8B USD | 41 | 41 |
| 210 | 15.7B USD | 41 | 33 |